clarithromycin
Experimental TherapeuticsHigh-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans DiseaseBuruli ulcer (BU), caused by Mycobacterium ulcerans, is a neglected tropical skin and soft tissue infection that is associated with disability and social stigma. The mainstay of BU treatment is an 8-week course of rifampin (RIF) at 10 mg/kg of body weight and 150 mg/kg streptomycin (STR).
Epidemiology and SurveillanceEmergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017The objective of this study was to determine the prevalence of Rhodococcus equi strains resistant to macrolides and rifampin over time in clinical samples from foals submitted to diagnostic laboratories in central Kentucky. We performed a retrospective observational study of all clinical samples from foals that were submitted to veterinary diagnostic laboratories in...
- Epidemiology and SurveillanceSystematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides
- Mechanisms of ResistanceSelection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies